Evidence map›Paper›PMID 40419522›Full record

ArticleScientific reports2025

Serum starvation-induced cholesterol reduction increases melanoma cell susceptibility to cytotoxic T lymphocyte killing.

Miaomiao Hou, Longtao Ji, Dimin Li, Qian Xiao, Xiao Hu

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Miaomiao HouJiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China.
Longtao JiInstitute of Modern Biology, Nanjing University, Nanjing, China.
Dimin LiJiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China.
Qian XiaoInstitute of Modern Biology, Nanjing University, Nanjing, China.
Xiao HuJiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China. xiao.hu@pumcderm.cams.cn.

Funding

National Natural Science Foundation of China 82273498Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences 2021-RC320-002
6 · The paper itself

Abstract

While calorie restriction has been suggested to reduce tumor incidence and slow tumor progression through promoting anti-tumor immune response, evidence disclosing how absence of specific nutrient component and alterations of its related metabolic pathways contribute to the process of anti-tumor immune response is still vague. Using human HLA-A*02:01 restricted New York esophageal squamous cell carcinoma-1 (NY-ESO-1) T cell receptor-engineered T (TCR-T) cells as a tool to investigate the impact from nutrient factors on tumor cells for targeted cytotoxicity, we serum-starved both human and murine melanoma cells and monitored their responses to TCR-T cell killing. Serum starvation sensitizes melanoma cells predominantly by reducing cholesterol availability without causing unwanted off-target effect, as supplementation of cholesterol compromises the sensitization toward TCR-T cell killing. In response to serum starvation, tumor cells upregulate cholesterol biogenesis pathways as a compensatory mechanism. Our study reveals the critical role of cholesterol reduction in mediating serum starvation-induced enhancement of anti-tumor immune response, highlighting the importance of plasma membrane composition in determining tumor cell response to TCR-T cell killing.

Indexed as

CholesterolCytotoxicity, ImmunologicMelanomaT-Lymphocytes, CytotoxicAnimalsCell Line, TumorHumansMiceReceptors, Antigen, T-CellCholesterolReceptors, Antigen, T-Cell

Identifiers

PMID40419522
PMCPMC12106750

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.